Discovery of Marburg virus neutralizing antibodies from virus-naïve human antibody repertoires using large-scale structural predictions
Nina G. Bozhanova(Howard Hughes Medical Institute), Jens Meiler(Leipzig University of Applied Sciences), Alexander Bukreyev(Galveston College), Kai Huang(Galveston College), Pavlo Gilchuk(AstraZeneca (Japan)), James E. Crowe(Vanderbilt University Medical Center), Rachel S. Nargi(Vanderbilt University Medical Center), Alexander M. Sevy(Merck & Co., Inc., Rahway, NJ, USA (United States)), Andrew Trivette, Amandeep K. Sangha(Vanderbilt University), Joseph X. Reidy(Vanderbilt University Medical Center), Robert H. Carnahan(Vanderbilt University Medical Center)
Cited by 21
Related Papers
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
|Cell Host & Microbe|2020|1.2k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
|Nature Medicine|2020|543
Taxonomy of the order Mononegavirales: update 2016
|Archives of Virology|2016|506